healthdigest.com on MSN

5 celebrities who kept their lupus diagnoses from the spotlight

A lot of good can come when celebrities speak out about their medical diagnoses. However, these celebs say they initially ...
PR Newswire

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use ...

‘Well, I’m doomed’: How this cancer treatment can help men live longer

Howard Smith’s urologist told him his prostate cancer was not the kind you die with: “It’s the one that’s going to kill you.” ...

The Literacy of Being Able to Say, 'I Will Not Perform the Treatment Today'

For an esthetic salon, deciding to forgo a treatment even when a reservation is booked is not a very pleasant decision. The ...
FT Markets

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
BioSpace

Ionis partner GSK announces Hibsago (bepirovirsen) approved in the U.S. for the treatment of chronic hepatitis B (CHB)

Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...
Northamptonshire Telegraph

Corby patients invited to help shape their Urgent Treatment Centre UTC

DHU Healthcare is asking the people of Corby to get involved in helping to shape the future of the town’s Urgent Treatment ...
BioSpace

Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)

Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...
FT Markets

Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan

BRINSUPRI is the first and only approved and commercially available treatment for patients diagnosed with NCFB in Japan. The Japan Ministry of Health, Labour, and Welfare (MHLW) approved BRINSUPRI in ...

Rashes, tonsillitis & bruising… alarmingly vague signs of ‘deadliest disease’ often mistaken for stress we almost missed

WHEN Dora Winslet woke up with blood on her pillow one day, she assumed she had scratched herself in her sleep. The ...
The National

Beauty during breast cancer treatment: Products to use and ingredients to avoid

Cancer drugs can cause skin to thin, bruise and crack, so here are items, routines and adaptations experts suggest to ...